The purpose of this study is to assess the ability of the Fluids Monitor to detect hemispheric bioimpedance asymmetry associated with acute brain pathology in patients presenting with suspected Acute Ischemic Stroke (AIS).
A prospective non-significant-risk (NSR) multi-site observational study. This study will examine up to 318 subjects undergoing evaluation for acute brain pathology who directly arrive at, or are transferred to, the participating sites.
Study Type
OBSERVATIONAL
Enrollment
287
Bioimpedance asymmetry
Lyerly Baptist, Inc
Jacksonville, Florida, United States
University of Buffalo
Buffalo, New York, United States
The Mount Sinai Hospital
New York, New York, United States
Medical University of South Carolina
Charleston, South Carolina, United States
University of Tennessee Health Science Center
Memphis, Tennessee, United States
Hemispheric bioimpedance asymmetry detection
The primary outcome will be the device's ability to detect hemispheric bioimpedance asymmetry associated with acute brain pathology in a population of patients presenting with symptoms consistent with AIS
Time frame: At the time of VIPS monitoring - day 0
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.